Compare AdaptHealth Corp (AHCO) vs Honest Company Inc (HNST) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

HNST trades at $3.94, up 1.03% with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $0.01, meeting expectations, but maintains negative net income margins. Revenue declined to $371.32M in 2025 from $378M in 2024, though gross margins improved to 33.89%. Operating cash flow strengthened to $15.12M, supporting liquidity. Analyst sentiment is mixed with 30% buy ratings amid ongoing profitability challenges.

The outlook remains cautious due to persistent net losses and revenue volatility. Investment appeal hinges on margin expansion and sustained cash flow generation. Key risks include competitive pressures in personal care and execution on growth initiatives. The stock's elevated P/E of 48.83 suggests high expectations for future earnings recovery.